Palm (PALM) Already weak company in the same sector as iPhone, Dragged down by bad news from Apple (AAPL). Falls to $4.25 from 52-week high of $19.50.
Human Genome Sciences (HGSI) Clinical trials set-back. Falls to $5.22 from 52-week high of $12.12.
Ciena (CIEN) Market does not like latest acquisition. Trades off to $21.40 from 52-week high of $49.55.
Motorola (MOT) Just when no one thought it could get worse. Shares drop to $9.43 from 52-week high of $19.98.
Qimonda Ag (QI) Weak results and downgrades for semiconductor company. Falls off to $3.51 from 52-week high of $17.29.
Douglas A. McIntyre
RSS Updates
Email Updates
